Insider Transactions in Q1 2024 at Lantern Pharma Inc. (LTRN)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 29
2024
|
Leslie W. Kreis > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,703
-2.95%
|
$78,812
$4.87 P/Share
|
Feb 29
2024
|
Aaron G.L. Fletcher > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,703
-2.95%
|
$78,812
$4.87 P/Share
|
Feb 28
2024
|
Leslie W. Kreis > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
74,297
-10.01%
|
$297,188
$4.85 P/Share
|
Feb 28
2024
|
Aaron G.L. Fletcher > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
74,297
-10.01%
|
$297,188
$4.85 P/Share
|
Feb 27
2024
|
Leslie W. Kreis > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50,000
-6.31%
|
$200,000
$4.4 P/Share
|
Feb 27
2024
|
Aaron G.L. Fletcher > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50,000
-6.31%
|
$200,000
$4.4 P/Share
|
Jan 17
2024
|
Leslie W. Kreis > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
58,889
-6.92%
|
$235,556
$4.2 P/Share
|
Jan 17
2024
|
Leslie W. Kreis > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
79,021
+8.5%
|
$237,063
$3.13 P/Share
|
Jan 17
2024
|
Aaron G.L. Fletcher > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
58,889
-6.92%
|
$235,556
$4.2 P/Share
|
Jan 17
2024
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
79,021
+8.5%
|
$237,063
$3.13 P/Share
|